Needham & Company LLC Has Lowered Expectations for Nurix Therapeutics (NASDAQ:NRIX) Stock Price
Nurix Therapeutics (NASDAQ:NRIX – Free Report) had its price objective decreased by Needham & Company LLC from $28.00 to $27.00 in a report published on Wednesday,Benzinga reports. Needham & Company LLC currently has a buy rating on the stock. Other equities research analysts have also recently issued research reports about the stock. JPMorgan Chase & […]
Nurix Therapeutics (NASDAQ:NRIX – Free Report) had its price objective decreased by Needham & Company LLC from $28.00 to $27.00 in a report published on Wednesday,Benzinga reports. Needham & Company LLC currently has a buy rating on the stock. Other equities research analysts have also recently issued research reports about the stock. JPMorgan Chase & […]
